Free cash flow turned negative at -$10M in 2026Q2, down from $270M in 2025Q4, with operating cash flow falling to 0.79x net income, indicating deteriorating earnings conversion.
Ingredion Incorporated (INGR) cash flow statement — 29-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 |
|---|
| Cash from Operations | 805M | 944M | 1.44B | 1.06B | 152M | 392M | 829M | 680M | 703M | 769M | 771M | 686M | 731M | 619M | 732M | 300M | 394M | 586M | -79M | 258M | 230M | 245M | 166M | 236M | 206M | 171M | 212M | 198M | 90M | 215M |
| Operating CF Margin % | - | 13.08% | 19.33% | 12.95% | 1.91% | 5.69% | 13.85% | 10.95% | 11.18% | 12.44% | 12.8% | 11.51% | 12.19% | 9.3% | 10.66% | 4.82% | 9.02% | 15.96% | -2% | 7.61% | 8.78% | 10.38% | 7.27% | 11.23% | 11.01% | 9.06% | 11.37% | 11.41% | 6.22% | 15.16% |
| Operating CF Growth % | -157.78% | -34.26% | 35.86% | 595.39% | -61.22% | -52.71% | 21.91% | -3.27% | -8.58% | -0.26% | 12.39% | -6.16% | 18.09% | -15.44% | 144% | -23.86% | -32.76% | 841.77% | -130.62% | 12.17% | -6.12% | 47.59% | -29.66% | 14.56% | 20.47% | -19.34% | 7.07% | 120% | -58.14% | - |
| Net Income | 592M | 729M | 647M | 643M | 502M | 117M | 348M | 413M | 454M | 532M | 496M | 412M | 363M | 403M | 433M | 423M | 176M | 47M | 267M | 198M | 124M | 90M | 94M | 76M | 63M | 57M | 48M | 77M | 43M | -72M |
| Depreciation & Amortization | 224M | 222M | 214M | 219M | 215M | 220M | 213M | 220M | 247M | 209M | 196M | 194M | 195M | 194M | 211M | 211M | 155M | 130M | 128M | 125M | 114M | 106M | 102M | 101M | 103M | 127M | 135M | 122M | 95M | 103M |
| Stock-Based Compensation | -12M | 0 | 46M | 20M | 29M | 23M | 23M | 18M | 21M | 26M | 28M | 21M | 19M | 17M | 18M | 0 | 6M | 5M | 5M | 0 | 0 | 0 | 0 | 0 | 0 | 9M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 6M | 6M | -15M | -6M | -3M | 0 | 0 | 0 | -23M | 67M | -5M | -6M | -11M | 30M | -3M | 18M | -30M | -5M | 12M | 7M | -6M | -16M | -9M | 4M | -6M | 2M | 15M | 7M | 10M | 10M |
| Other Non-Cash Items | 111M | 127M | 74M | 119M | 73M | 538M | 219M | 134M | 142M | 73M | 87M | 104M | 56M | 79M | 31M | 12M | 42M | 152M | -33M | 1M | 4M | 5M | 27M | 9M | -7M | 3M | 18M | 0 | 0 | 120M |
| Working Capital Changes | -119M | -140M | 470M | 62M | -664M | -506M | 26M | -105M | -118M | -121M | -8M | -24M | 84M | -57M | 33M | -304M | 45M | 257M | -458M | -59M | -29M | 60M | -48M | 46M | 53M | -18M | -4M | -8M | -58M | 54M |
| Change in Receivables | 352M | -51M | 148M | 77M | -310M | -162M | -3M | -61M | -70M | -44M | -131M | -29M | -15M | -69M | 22M | -134M | -45M | -3M | -43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -2M | 3M | 228M | 69M | -468M | -312M | -14M | -43M | -50M | -34M | -19M | 9M | -6M | 76M | -69M | -149M | -51M | 82M | -91M | -86M | -57M | 5M | -34M | -11M | -6M | 20M | -12M | -28M | -32M | 34M |
| Change in Payables | 25M | -27M | 20M | -79M | 158M | 0 | 0 | 0 | -3M | -49M | 150M | 20M | 21M | -7M | 47M | 283M | 96M | -79M | -29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -338M | -444M | -47M | -329M | -320M | -335M | -571M | -374M | -361M | -326M | -689M | -649M | -294M | -274M | -322M | -273M | -1.43B | -145M | -219M | -232M | -210M | -141M | -149M | -130M | -73M | -171M | -262M | -271M | -60M | -133M |
| Capital Expenditures | -152M | -433M | -301M | -316M | -300M | -300M | -340M | -328M | -349M | -306M | -283M | -277M | -271M | -295M | -304M | -260M | -156M | -141M | -219M | -177M | -171M | -143M | -104M | -83M | -78M | -94M | -143M | -280M | -122M | -116M |
| CapEx % of Revenue | 2.11% | 6% | 4.05% | 3.87% | 3.78% | 4.35% | 5.68% | 5.28% | 5.55% | 4.95% | 4.7% | 4.65% | 4.52% | 4.43% | 4.43% | 4.18% | 3.57% | 3.84% | 5.55% | 5.22% | 6.52% | 6.06% | 4.56% | 3.95% | 4.17% | 4.98% | 7.67% | 16.14% | 8.43% | 8.18% |
| Acquisitions | 24M | 12M | 0 | 0 | -29M | -40M | -236M | -42M | -15M | -17M | -409M | -434M | -5M | 0 | 0 | -15M | -1.27B | -4M | 0 | -59M | -42M | -5M | -68M | -48M | -42M | -79M | -120M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -201M | -3M | 254M | -13M | 9M | 5M | 5M | -4M | 1M | 8M | 3M | 38M | 5M | 2M | -9M | 2M | 0 | -4M | 0 | 4M | 3M | 7M | 1M | 1M | 47M | 2M | 1M | 9M | 62M | -17M |
| Cash from Financing | -381M | -491M | -765M | -569M | 103M | -373M | 143M | -364M | -589M | -375M | 0 | -116M | -388M | -353M | -197M | 86M | 1.16B | -375M | 230M | 15M | -6M | -91M | 13M | -73M | -159M | 27M | 50M | 75M | -79M | -29M |
| Debt Issued (Net) | 2M | -44M | -345M | -292M | 433M | -390M | 326M | -256M | 249M | -96M | 120M | 22M | 18M | -32M | -150M | 160M | 1.21B | -332M | 257M | 83M | 16M | -44M | 6M | -58M | -144M | 46M | 132M | 100M | -96M | 0 |
| Equity Issued (Net) | -183M | -224M | -216M | -101M | -112M | -68M | 0 | 0 | -657M | -123M | 21M | -20M | -284M | -214M | 16M | -30M | 17M | 1M | 10M | -39M | -2M | -25M | 30M | 5M | 4M | 4M | -44M | -19M | -1M | 0 |
| Dividends Paid | -210M | -211M | -210M | -194M | -181M | -184M | -170M | -174M | -173M | -165M | -141M | -126M | -128M | -112M | -69M | -50M | -45M | -45M | -42M | -33M | -26M | -22M | -23M | -20M | -19M | -23M | -14M | -13M | -3M | 0 |
| Share Repurchases | -183M | -224M | -216M | -101M | -112M | -68M | 0 | 0 | -657M | -123M | -8M | -41M | -304M | -228M | -18M | -48M | -5M | -3M | -1M | -55M | -23M | -25M | 0 | 0 | 0 | 0 | -44M | -19M | -1M | 0 |
| Other Financing | 10M | -12M | 6M | 18M | -37M | 269M | -13M | 66M | 1M | 9M | -6M | 8M | 6M | 5M | 6M | 6M | -32M | -2M | 1M | 0 | 6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21M | -29M |
| Net Change in Cash | 87M | 33M | 596M | 165M | -92M | -337M | 401M | -63M | -268M | 83M | 78M | -146M | 6M | -35M | 208M | 99M | 127M | 68M | -68M | 44M | 15M | 15M | 31M | 34M | -29M | 24M | 0 | 5M | -49M | 53M |
| Free Cash Flow | 653M | 511M | 1.14B | 741M | -148M | 92M | 489M | 352M | 354M | 463M | 488M | 409M | 460M | 324M | 428M | 40M | 238M | 445M | -298M | 81M | 59M | 102M | 62M | 153M | 128M | 77M | 69M | -82M | -32M | 99M |
| FCF Margin % | 9.05% | 7.08% | 15.28% | 9.08% | -1.86% | 1.33% | 8.17% | 5.67% | 5.63% | 7.49% | 8.1% | 6.86% | 7.67% | 4.87% | 6.23% | 0.64% | 5.45% | 12.12% | -7.56% | 2.39% | 2.25% | 4.32% | 2.72% | 7.28% | 6.84% | 4.08% | 3.7% | -4.73% | -2.21% | 6.98% |
| FCF Growth % | -18.68% | -54.98% | 53.17% | 600.68% | -260.87% | -81.19% | 38.92% | -0.56% | -23.54% | -5.12% | 19.32% | -11.09% | 41.98% | -24.3% | 970% | -83.19% | -46.52% | 249.33% | -467.9% | 37.29% | -42.16% | 64.52% | -59.48% | 19.53% | 66.23% | 11.59% | 184.15% | -156.25% | -132.32% | - |
| FCF per Share | 10.22 | 7.84 | 17.04 | 11.06 | -2.21 | 1.36 | 7.23 | 5.22 | 4.93 | 6.30 | 6.59 | 5.60 | 6.14 | 4.14 | 5.47 | 0.51 | 3.10 | 5.89 | -3.93 | 1.06 | 0.78 | 1.35 | 0.83 | 2.11 | 1.79 | 1.08 | 0.98 | -1.10 | -0.44 | 1.39 |
| FCF Conversion (FCF/Net Income) | 1.10x | 1.29x | 2.22x | 1.64x | 0.31x | 3.35x | 2.38x | 1.65x | 1.59x | 1.48x | 1.59x | 1.71x | 2.06x | 1.56x | 1.71x | 0.72x | 2.33x | 14.26x | -0.30x | 1.30x | 1.85x | 2.72x | 1.77x | 3.11x | 3.27x | 3.00x | 4.42x | 2.57x | 2.09x | -2.87x |
| Interest Paid | 0 | 0 | 48M | 96M | 82M | 72M | 78M | 80M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 169M | 157M | 187M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying INGR stock.
Ingredion Incorporated (INGR) generated $944.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Ingredion Incorporated (INGR) generated $511.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Ingredion Incorporated (INGR) spent $433.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Ingredion Incorporated (INGR) returned $211.0M to shareholders via cash dividends and spent $224.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Working capital volatility persists
Metrics are mathematically derived from official filings.
Earnings Quality Deteriorates in 2026
Operating cash flow fell to 0.79x net income in 2026Q2, down from 2.45x in 2025Q4, according to Ingredion's quarterly cash flow statements, signaling a sharp decline in earnings conversion.
The OCF/NI ratio has been erratic, swinging from 4.59x in 2024Q4 to 0.23x in 2026Q1, indicating that reported earnings are not consistently translating into cash. The recent quarters show a negative working capital impact, with WC Chg of -$55M and -$195M in 2026Q2 and Q1, respectively, suggesting that cash is being tied up in operations. This volatility may reflect timing of collections and inventory builds, but the sustained low conversion in early 2026 warrants close monitoring.
Free Cash Flow Turns Negative
Ingredion's free cash flow was -$10M in 2026Q2 and -$77M in 2026Q1, a stark reversal from the $270M generated in 2025Q4, based on reported quarterly cash flow data.
The FCF margin has swung from 15.4% in 2025Q4 to -4.3% in 2026Q1, indicating that the company is not generating sufficient cash to cover capital expenditures in recent quarters. This deterioration is driven by a combination of elevated capex (over $100M per quarter) and weak operating cash flow, which fell to $33M in 2026Q1. The negative FCF may be a seasonal pattern, but the magnitude of the swing suggests that the company's cash generation is highly sensitive to working capital dynamics.
Capital Intensity Rises Sharply
CapEx as a percentage of revenue climbed to 5.4% in 2026Q2, up from 2.7% in 2024Q3, according to Ingredion's cash flow statements, indicating a significant increase in capital spending.
The company has been investing heavily in its specialty ingredients and plant conversions, with quarterly capex exceeding $100M in 2026. This elevated capital intensity may be aimed at expanding higher-margin product lines, but it is also pressuring free cash flow. Given the prior income statement analysis showing operating margin compression, the increased capex may not yet be yielding the expected returns, and investors should monitor whether these investments translate into improved cash generation.
Working Capital Swings Drive Cash Flow
Working capital changes swung from a positive $141M in 2025Q4 to a negative $195M in 2026Q1, based on Ingredion's quarterly cash flow data, highlighting significant volatility in cash conversion.
The large negative working capital adjustments in early 2026 suggest that the company is building inventory or facing slower collections, which is consuming cash. This pattern is consistent with the prior income statement analysis showing revenue declines, as customers may be delaying payments or the company is stocking up on raw materials. The erratic working capital changes make it difficult to predict cash flow, and management's ability to stabilize these swings will be critical for maintaining dividend coverage.
Dividends and Buybacks Persist Despite Cash Strain
Ingredion paid $53M in dividends and repurchased $14M of stock in 2026Q2, even as free cash flow was negative, according to reported cash flow data, indicating a commitment to shareholder returns.
The company has consistently paid dividends of around $52-54M per quarter, and buybacks have been variable, with $90M in 2025Q4 and $129M in 2024Q4. However, in 2026Q1 and Q2, buybacks were minimal, possibly to conserve cash. The continued dividend payments despite negative FCF suggest that management is prioritizing shareholder returns, but this may be unsustainable if cash flow does not improve. The company may need to rely on debt or existing cash reserves to fund these distributions.
Cumulative Cash Lags Net Income
Over the last ten quarters, Ingredion's cumulative operating cash flow of $2.5B is below cumulative net income of $1.6B, based on reported quarterly data, indicating a persistent gap between earnings and cash.
While the cumulative OCF exceeds net income, the gap has narrowed recently, and the quarterly conversion has been inconsistent. The divergence is particularly pronounced in 2026, where net income of $256M in Q1 and Q2 contrasts with operating cash flow of only $123M, implying that earnings are not being fully realized as cash. This may be due to working capital buildup or other non-cash adjustments, and it raises questions about the quality of earnings. Investors should monitor whether this gap narrows as the company's mix shift progresses.
What Could Invalidate the Base Case
The negative working capital swings in 2026Q1 and Q2 may obscure a stronger underlying cash flow trend, as reported in Ingredion's cash flow statements, suggesting the recent deterioration could be temporary.
The sharp negative working capital adjustments in early 2026 could be due to seasonal inventory builds or timing of payables, which may reverse in subsequent quarters. If the company's specialty ingredients growth continues, the elevated capex could lead to higher future cash flows. However, the persistent revenue decline and margin compression could indicate that the cash flow strain is structural, not just seasonal. Investors should watch for a rebound in working capital and sustained improvement in OCF/NI to confirm the base case.